| CRISPR Medicine | This is an overview of all our articles
Updated Phase 1 data presented at the 2026 American Society of Gene and Cell Therapy (ASGCT) meeting suggest that Fate Therapeutics’ off-the-shelf CAR...
When clinicians at the Children’s Hospital of Philadelphia (CHOP) treated baby KJ – born with a rare, often-fatal urea-cycle disorder – with a CRISPR...
Intellia Therapeutics has initiated a rolling biologics license application (BLA) with the U.S. Food and Drug Administration for lonvoguran ziclumeran...
A new regulatory framework proposed in February by the US Food and Drug Administration could dramatically reduce the time and cost of bringing...
A genome-wide CRISPR-Cas9 loss-of-function screening platform developed for primary human natural killer cells has identified several intracellular...
A new study from Stanford University combines CRISPR activation with single-cell and spatial approaches to identify mechanisms that enhance T...
A Chinese research team has developed TIGER (Template-Independent Genome Editing for Restoration), a CRISPR-Cas9 platform that corrects frameshift...
Some of the best links we picked up around the internet
